GSK trial proves RSV vaccine efficacy after three full seasons
2024年10月8日 - 9:18PM
Alliance News
GSK PLC on Tuesday
said its Arexvy treatment was effective in treating patients
suffering from a deadly respiratory v ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Gsk (LSE:GSK)
過去 株価チャート
から 11 2024 まで 12 2024
Gsk (LSE:GSK)
過去 株価チャート
から 12 2023 まで 12 2024